KS Vidhya, A Sultana, N Kumar, H Rangareddy… - Cureus, 2023 - cureus.com
Artificial intelligence (AI) techniques have the potential to revolutionize drug release modeling, optimize therapy for personalized medicine, and minimize side effects. By …
P Clayden - 2015 PIPELINE REPORT, 2015 - issuelab.org
Fit For Purpose: Antiretroviral Treatment Optimization Page 49 43 Antiretroviral Treatment Optimization Fit for Purpose: Antiretroviral Treatment Optimization By Polly Clayden …
A Affan, T Inanc - 2021 IEEE/ACM Conference on Connected …, 2021 - ieeexplore.ieee.org
Drug delivery for warfarin and anemia management is a difficult task due to narrow therapeutic range and change in patient's Pharmacokinetic (PK) and Pharmacodynamic …
Motivation: Optimizing HIV therapies is crucial since the virus rapidly develops mutations to evade drug pressure. Recent studies have shown that genotypic information might not be …
CC Ebulue, OV Ekkeh, OR Ebulue… - … Science Research Journal, 2024 - fepbl.com
This paper proposes a novel approach to combating HIV drug resistance through the development of predictive models leveraging genomic data and artificial intelligence (AI) …
MTJ Patvegar, A Patil, R Jarag, P Sathe… - International …, 2024 - researchgate.net
Artificial intelligence (AI) is driving personalized medicine, which is changing the face of pharmaceutical research and patient treatment. AI algorithms sift through mountains of …
For a long time, the clinical management of antiretroviral drug resistance was based on sequence analysis of the HIV genome followed by estimating drug susceptibility from the …
M Jafari, A Shamipak, F Shahsavari… - Personalized Medicine …, 2023 - pmjournal.ir
The enormous genetic variety of the viral population harbored by the patient and the large volume of therapeutic alternatives characterize HIV therapy. Each patient and period has its …
Background More than half of persons living with HIV (PLWH) in the United States are insufficiently engaged in HIV primary care and not taking antiretroviral therapy (ART), mainly …